TY - JOUR
T1 - Aetiology, course and treatment of acute tubulointerstitial nephritis in paediatric patients
T2 - A cross-sectional web-based survey
AU - The international TIN study group
AU - Wente-Schulz, Sarah
AU - Aksenova, Marina
AU - Awan, Atif
AU - Ambarsari, Cahyani Gita
AU - Becherucci, Francesca
AU - Emma, Francesco
AU - Fila, Marc
AU - Francisco, Telma
AU - Gokce, Ibrahim
AU - Gülhan, Bora
AU - Hansen, Matthias
AU - Jahnukainen, Timo
AU - Kallash, Mahmoud
AU - Kamperis, Konstantinos
AU - Mason, Sherene
AU - Mastrangelo, Antonio
AU - Mencarelli, Francesca
AU - Niwinska-Faryna, Bogna
AU - Riordan, Michael
AU - Rus, Rina R.
AU - Saygili, Seha
AU - Serdaroglu, Erkin
AU - Taner, Sevgin
AU - Topaloglu, Rezan
AU - Vidal, Enrico
AU - Woroniecki, Robert
AU - Yel, Sibel
AU - Zieg, Jakub
AU - Pape, Lars
AU - Boyer, Olivia
AU - Buder, Kathrin
AU - Bulut, İpek Kaplan
AU - Cornelissen, Elisabeth A.M.
AU - del Mar Espino Hernández, Maria
AU - Hooman, Nakysa
AU - Kemper, Markus
AU - Maquet, Julie
AU - Santos, Fernando
AU - Walden, Ulrike
N1 - Publisher Copyright: © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
PY - 2021/5/28
Y1 - 2021/5/28
N2 - Background Acute tubulointerstitial nephritis (TIN) is a significant cause of acute renal failure in paediatric and adult patients. There are no large paediatric series focusing on the aetiology, treatment and courses of acute TIN. Patients, design and setting We collected retrospective clinical data from paediatric patients with acute biopsy-proven TIN by means of an online survey. Members of four professional societies were invited to participate. Results Thirty-nine physicians from 18 countries responded. 171 patients with acute TIN were included (54% female, median age 12 years). The most frequent causes were tubulointerstitial nephritis and uveitis syndrome in 31% and drug-induced TIN in 30% (the majority of these caused by non-steroidal anti-inflammatory drugs). In 28% of patients, no initiating noxae were identified (idiopathic TIN). Median estimated glomerular filtration rate (eGFR) rose significantly from 31 at time of renal biopsy to 86 mL/ min/1.73 m2 3-6 months later (p<0.001). After 3-6 months, eGFR normalised in 41% of patients (eGFR ≥90 mL/ min/1.73 m2), with only 3% having severe or end-stage impairment of renal function (<30 mL/min/1.73 m2). 80% of patients received corticosteroid therapy. Median eGFR after 3-6 months did not differ between steroid-treated and steroid-untreated patients. Other immunosuppressants were used in 18% (n=31) of patients, 21 of whom received mycophenolate mofetil. Conclusions Despite different aetiologies, acute paediatric TIN had a favourable outcome overall with 88% of patients showing no or mild impairment of eGFR after 3-6 months. Prospective randomised controlled trials are needed to evaluate the efficacy of glucocorticoid treatment in paediatric patients with acute TIN.
AB - Background Acute tubulointerstitial nephritis (TIN) is a significant cause of acute renal failure in paediatric and adult patients. There are no large paediatric series focusing on the aetiology, treatment and courses of acute TIN. Patients, design and setting We collected retrospective clinical data from paediatric patients with acute biopsy-proven TIN by means of an online survey. Members of four professional societies were invited to participate. Results Thirty-nine physicians from 18 countries responded. 171 patients with acute TIN were included (54% female, median age 12 years). The most frequent causes were tubulointerstitial nephritis and uveitis syndrome in 31% and drug-induced TIN in 30% (the majority of these caused by non-steroidal anti-inflammatory drugs). In 28% of patients, no initiating noxae were identified (idiopathic TIN). Median estimated glomerular filtration rate (eGFR) rose significantly from 31 at time of renal biopsy to 86 mL/ min/1.73 m2 3-6 months later (p<0.001). After 3-6 months, eGFR normalised in 41% of patients (eGFR ≥90 mL/ min/1.73 m2), with only 3% having severe or end-stage impairment of renal function (<30 mL/min/1.73 m2). 80% of patients received corticosteroid therapy. Median eGFR after 3-6 months did not differ between steroid-treated and steroid-untreated patients. Other immunosuppressants were used in 18% (n=31) of patients, 21 of whom received mycophenolate mofetil. Conclusions Despite different aetiologies, acute paediatric TIN had a favourable outcome overall with 88% of patients showing no or mild impairment of eGFR after 3-6 months. Prospective randomised controlled trials are needed to evaluate the efficacy of glucocorticoid treatment in paediatric patients with acute TIN.
UR - https://www.scopus.com/pages/publications/85107244372
U2 - 10.1136/bmjopen-2020-047059
DO - 10.1136/bmjopen-2020-047059
M3 - Article
C2 - 34049919
SN - 2044-6055
VL - 11
JO - BMJ Open
JF - BMJ Open
IS - 5
M1 - e047059
ER -